ZYVERSA THERAPEUTICS, INC. Shareholders' Equity
ZYVERSA THERAPEUTICS, INC. (ZVSA) had Shareholders' Equity of -$14.12 million as of 2026-03-31, per its 10-Q filed 2026-05-13.
Financial Statements › Balance Sheet › Equity › Equity, Attributable to Parent
us-gaap:StockholdersEquity · last filed 2026-05-13
- 2026-03-31: Stockholders' Equity Attributable to Parent -$14.12M.
- 2025-12-31: Stockholders' Equity Attributable to Parent -$12.39M.
- 2025-09-30: Stockholders' Equity Attributable to Parent -$11.73M.
- 2025-06-30: Stockholders' Equity Attributable to Parent $6.10M.
| Period end | Stockholders' Equity Attributable to Parent |
|---|---|
| 2026-03-31 | -$14.12M 10-Q · filed 2026-05-13 |
| 2025-12-31 | -$12.39M 10-Q · filed 2026-05-13 |
| 2025-09-30 | -$11.73M 10-Q · filed 2025-11-19 |
| 2025-06-30 | $6.10M 10-Q · filed 2025-11-19 |
| 2025-03-31 | $8.13M 10-Q · filed 2026-05-13 |
| 2024-12-31 | $8.52M 10-Q · filed 2026-05-13 |
| 2024-09-30 | $7.03M 10-Q · filed 2025-11-19 |
| 2024-06-30 | $8.62M 10-Q · filed 2025-11-19 |
| 2024-03-31 | $11.22M 10-Q · filed 2025-11-19 |
| 2023-12-31 | $11.07M 10-K · filed 2026-03-31 |
| 2023-09-30 | $19.70M 10-Q · filed 2024-11-14 |
| 2023-06-30 | $20.06M 10-Q · filed 2024-11-14 |
| 2023-03-31 | $97.10M 10-Q · filed 2024-11-14 |
| 2022-12-31 | $99.66M 10-K · filed 2025-03-27 |
| 2022-12-12 | $99.68M 10-K · filed 2024-03-25 |
| 2022-09-30 | -$4.16M 10-Q · filed 2022-11-14 |
| 2022-06-30 | -$3.37M 10-Q · filed 2022-11-14 |
| 2022-03-31 | -$2.98M 10-Q · filed 2022-11-14 |
| 2021-12-31 | -$2.26M 10-Q · filed 2022-11-14 |
| 2021-09-30 | -$1.40K 10-Q · filed 2022-11-14 |
| 2021-06-30 | -$1.23K 10-Q · filed 2022-11-14 |
| 2021-03-31 | -$439.00 10-Q · filed 2022-11-14 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| BioXcel Therapeutics, Inc. (BTAI) | United States | $0.002B | |
| Matinas BioPharma Holdings, Inc. (MTNB) | United States | $0.003B | |
| JUPITER NEUROSCIENCES, INC. (JUNS) | United States | $0.002B | -0.02 |
| ORAGENICS INC (OGEN) | United States | $0.002B | |
| Petros Pharmaceuticals, Inc. (PTPI) | United States | $0.003B | |
| GeoVax Labs, Inc. (GOVX) | United States | $0.003B | -0.45 |
| Nexentis Technologies Inc. (NXTS) | $0.002B | ||
| Decoy Therapeutics Inc. (DCOY) | United States | $0.002B | -0.27 |
| Silo Pharma, Inc. (SILO) | United States | $0.003B | -1.57 |
| Genprex, Inc. (GNPX) | United States | $0.003B | -0.02 |